Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report

INTRODUCTION: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Med Case Rep
Main Authors: Dao, Abou, Benchakroun, Nadia, Jabir, Hamza, Taleb, Amina, Bouchbika, Zineb, Tawfiq, Nezha, Jouhadi, Hassan, Sahraoui, Souha, Benider, Abdellatif
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307220/
https://ncbi.nlm.nih.gov/pubmed/25488584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-416
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares